Biomaterial-Mediated Genetic Reprogramming of Merkel Cell Carcinoma and Melanoma Leads to Targeted Cancer Cell Killing In Vitro and In Vivo

[Image: see text] Tumor immunotherapy is a promising anticancer strategy; however, tumor cells may employ resistance mechanisms, including downregulation of major histocompatibility complex (MHC) molecules to avoid immune recognition. Here, we investigate reprogramming nanoparticles (NPs) that deliv...

Descripción completa

Detalles Bibliográficos
Autores principales: Luly, Kathryn M, Green, Jordan J, Sunshine, Joel C, Tzeng, Stephany Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646862/
https://www.ncbi.nlm.nih.gov/pubmed/37797944
http://dx.doi.org/10.1021/acsbiomaterials.3c00885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646862/
https://www.ncbi.nlm.nih.gov/pubmed/37797944
http://dx.doi.org/10.1021/acsbiomaterials.3c00885

Ejemplares similares